TRT Prescriptions Jump 1,100% as Testosterone Therapy Spreads Beyond Deficiency Care
Updated
Updated · Fitt Insider · Jul 27
TRT Prescriptions Jump 1,100% as Testosterone Therapy Spreads Beyond Deficiency Care
1 articles · Updated · Fitt Insider · Jul 27
Summary
Testosterone replacement therapy is shifting from a treatment for clinically low levels into a broader wellness product pitched for performance, longevity and masculinity.
FDA easing of TRT safety warnings, MAHA-backed messaging and new Defense Department screening for service members 30 and older are widening access and normalizing use.
IQVIA data show prescriptions rose 1,100% from 2000 to 2025 even though 65% of men over 40 have never been tested and about 55% cannot identify low-T symptoms.
190,000 Texans receive monthly TRT, with 40% getting it through compounding pharmacies, while some telehealth platforms are reportedly prescribing to men with normal testosterone levels.
Companies from Hims to Game Day Men’s Health are building new cash-pay and clinic models, but clinicians warn easier access could spur overtreatment, suppress natural production and cut sperm counts.